OUR MISSION

To transform the efficacy and safety of intracellularly active therapeutics, macromolecules, and biologics across the spectrum of health conditions through the application of our Endosomal Intracellular Penetration & Release (EIPR) platform, TANA-Porter™

KIET A. LY, MD, MPH, MS

President &
Chief Executive Officer

JEAN PHILIPPE PELLOIS, PHD

Chief Scientific Officer

GLORIA MACEIKO

Executive Advisor - Partnerships

HUCK HOLZ, MD

Chief Medical Officer

CEDRIC G. GEOFFROY, PHD

Associate CSO

CHRIS SARKISS, MD

Head of Therapeutics Development

DAN LEE, MD, PHD

R&D Medical Advisor

RAMIN ZACHARIA

Finance Advisor